Joel Greenblatt acquired 342k Amedisys shares worth $34.6M. That's 0.20% of their equity portfolio (54th largest holding). The investor owns 1.04% of the outstanding Amedisys stock. The first Amedisys trade was made in Q4 2010. Since then Joel Greenblatt bought shares 27 more times and sold shares on seventeen occasions. The stake costed the investor $33.3M, netting the investor a gain of 3.8% so far.